Fundz

Fundz Deep Dive

Everything you need to win Elizabeth Adkins Czerepak — in one platform.

Who to reach, what to say, and why now on Elizabeth Adkins Czerepak — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Elizabeth Adkins Czerepak — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Mirror Biologics Appoints Elizabeth Adkins Czerepak As Chief Financial Officer and Vice President of Corporate Development

PRIVATEApr 18, 2024about 2 years ago

Position

Chief Financial Officer

Company

Mirror Biologics

Elizabeth Adkins Czerepak
Wesley ChapelManufacturingBiotechnologyTherapeutics

Description

Mirror Biologics, Inc. announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024.

Company Information

Company

Mirror Biologics

Location

Wesley Chapel, Florida, United States

About

Mirror Biologics, Inc. is a private Delaware corporation specializing in the discovery, clinical testing and manufacturing of next generation therapeutic and prophylactic immunotherapy and immunomodulatory products which incorporate non-genetically altered “off-the-shelf” living immune cells as the active ingredients.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Mirror Biologics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.